Quick answer: A copper blood test measures total circulating copper, and most of that copper is carried by ceruloplasmin, a liver protein that rises with inflammation. Higher copper and ceruloplasmin levels have been linked with coronary heart disease in large studies, while very low copper can reflect low intake, poor absorption or high zinc intake.
Copper is a trace mineral that the body needs in small amounts and handles with great care. It helps the mitochondria make energy, helps build collagen and connective tissue, supports the antioxidant enzyme superoxide dismutase, and helps move iron out of storage so it can be used to make red blood cells. Most of the copper in the blood rides on a single protein called ceruloplasmin, so the two are often tested together. My separate article on the zinc-to-copper ratio looks at the balance between those two minerals, while this article focuses on copper and ceruloplasmin on their own.
This article is educational. It explains what the marker reflects and how researchers connect it to the deeper mechanisms of aging, so you can have a more informed conversation with your own provider.
What do copper and ceruloplasmin tests measure?
A serum copper test measures the total copper in the liquid part of the blood. Ceruloplasmin is a protein made in the liver, and it carries most of that circulating copper while also acting as an enzyme that helps load iron onto transferrin, the iron transport protein. Because the two travel together, a copper result is usually read alongside ceruloplasmin. Some labs also estimate the small amount of copper that is not bound to ceruloplasmin, which is sometimes called free copper.
Ceruloplasmin is also an acute-phase protein, which means the liver makes more of it during inflammation, infection and tissue injury. Pregnancy, estrogen therapy and oral contraceptives raise it as well. That is why a higher copper or ceruloplasmin result often reflects inflammation or hormones rather than extra copper intake. Lower results can reflect low copper intake, poor absorption after some types of gut surgery, very high zinc intake, which blocks copper absorption, or rare inherited conditions that change how the body handles copper. Very low copper is linked with anemia, low white blood cell counts and nerve problems, so a low result deserves a careful look with your own provider.
How is copper connected to aging and root causes?
Copper sits right at the center of mitochondrial health. The last enzyme in the energy-making chain inside the mitochondria, cytochrome c oxidase, depends on copper, and so does one of the main antioxidant enzymes in the cell. When copper is too low, energy production and antioxidant defense can both suffer. That is one reason copper status matters for tired, aging tissues such as muscle, nerves and the heart.
Copper also has a darker side. Unbound copper can react with oxygen and help generate free radicals, which can damage fats, proteins and DNA. The body keeps copper tightly bound for exactly this reason. Researchers think that when more copper escapes those protective carriers, it may add to oxidative stress and chronic low-grade inflammation, two of the processes most closely tied to aging of the blood vessels and the brain. The research described below fits that picture, since higher copper and ceruloplasmin have been linked with heart disease and since a larger pool of copper not bound to ceruloplasmin has been reported in Alzheimer disease.
From a root-cause view, copper is less about a single number and more about balance and context. Intake from shellfish, organ meats, nuts, seeds, beans and whole grains, the amount of zinc someone takes, gut absorption, liver health, hormone use and the overall inflammatory load all shape the result. Because ceruloplasmin rises with inflammation, I find it most helpful to read copper and ceruloplasmin next to an inflammation marker such as hs-CRP, and next to iron markers, before drawing any conclusion about copper itself.
What does the research show about copper and ceruloplasmin?
One of the clearest population studies comes from the second National Health and Nutrition Examination Survey. In 2000 in the American Journal of Epidemiology, Ford followed 4,574 US adults aged 30 and older whose serum copper had been measured at baseline, and 151 of them later died from coronary heart disease. After adjusting for age, sex, smoking, blood pressure, cholesterol, body mass index, activity, diabetes and white blood cell count, the hazard ratios for coronary death in the second, third and fourth quarters of copper compared with the lowest quarter were 1.84, 2.14 and 2.87. The author noted that it remains unclear whether copper itself affects artery disease or simply marks the inflammation that travels with it, and copper was measured only once.
Ceruloplasmin has been studied directly in people with heart disease. In 2012 in Arteriosclerosis, Thrombosis, and Vascular Biology, Tang and colleagues measured serum ceruloplasmin in 4,177 patients having elective coronary angiography, with an average age of 63, and followed them for three years. The average level was 24 mg/dL. People in the highest quarter had 2.35 times the risk of a heart attack compared with the lowest quarter, and ceruloplasmin still predicted major cardiac events after adjustment for traditional risk factors, hs-CRP and kidney function, with a hazard ratio of 1.55. Interestingly, a gene variant that modestly raises ceruloplasmin was not linked with heart disease, which suggests that ceruloplasmin may be more of a marker than a cause. These were people already being evaluated for heart disease, so the results may not apply to healthy adults.
Copper distribution has also been studied in the aging brain. In 2005 in Neurology, Squitti and colleagues compared serum copper, ceruloplasmin and markers of oxidative stress in 47 people with Alzheimer disease, 24 people with vascular dementia and 44 healthy controls. Copper and peroxides were significantly higher and antioxidant capacity was lower in the Alzheimer group, and the ratio of copper to ceruloplasmin pointed to a larger pool of copper not bound to ceruloplasmin in Alzheimer disease but not in vascular dementia or in the controls. The study was small and measured everyone at a single point in time, so it cannot show whether the copper changes came before the memory changes.
Related reading
If you would like to explore related topics, my articles on the zinc-to-copper ratio, ferritin and IL-6 go deeper. You can also see the specialty tests I commonly recommend on my functional labs page.
Common questions about Copper and Ceruloplasmin
Why are copper and ceruloplasmin tested together?
Most of the copper in the blood is carried by ceruloplasmin, so the two numbers usually move together. Reading them side by side helps show whether a change in copper reflects the carrier protein or the copper that is not bound to it.
Can inflammation raise a copper level?
Yes. Ceruloplasmin is an acute-phase protein that the liver makes in larger amounts during inflammation, and pregnancy and estrogen use raise it as well, so serum copper can rise even when copper intake has not changed.
What can lower copper levels?
Low copper intake, poor absorption after some gut surgeries and long-term high zinc intake can all lower copper. Rare inherited conditions also change how copper is handled, which is why a low result is worth reviewing with your own provider.
Sources
This article is for educational purposes only and is not medical advice. It does not replace an individual evaluation. Talk with your healthcare provider before making changes to your diet, exercise, supplements, or medications, especially if you are pregnant, nursing, or managing a health condition.
Free: The 28-Day Reset for Energy and Focus
A simple day-by-day email guide to sleep, movement, food, and daily habits that support healthy aging. It’s free, and you can unsubscribe anytime.
Get the free guide Take the supplement quiz
